Localized US Efforts to Eliminate Hepatitis C

Annette Gaudino; Bryn Gay; Clifton Garmon; Mike Selick; Reed Vreeland; Katie Burk; Emalie Huriaux; Shelley N Facente; Annie Luetkemeyer; Phil Waters; Camilla S Graham

doi:10.1016/j.idc.2018.02.009

Localized US Efforts to Eliminate Hepatitis C

Infect Dis Clin North Am. 2018 Jun;32(2):293-311. doi: 10.1016/j.idc.2018.02.009.

Authors

Affiliations

¹ Treatment Action Group, 90 Broad Street, Suite 2503, New York, NY 10004, USA.
² VOCAL-NY, 80-A Fourth Avenue, Brooklyn, NY 11217, USA.
³ Harm Reduction Coalition, 22 West 27th Street, 5th Floor, New York, NY 10001, USA.
⁴ Housing Works, 57 Willoughby Street, 2nd Floor, Brooklyn, NY 11201, USA.
⁵ San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA.
⁶ Project Inform, 273 Ninth Street, San Francisco, CA 94103, USA.
⁷ Facente Consulting, 5601 Van Fleet Avenue, Richmond, CA 94804, USA.
⁸ Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General, University of California San Francisco, Box 0874, 995 Potrero Avenue, San Francisco, CA 94110, USA.
⁹ Center for Health Law and Policy Innovation, Harvard Law School, 122 Boylston Street, Jamaica Plain, MA 02130, USA.
¹⁰ Division of Infectious Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street LMOB Suite GB, Boston, MA 02215, USA. Electronic address: [email protected].

PMID: 29778257
DOI: 10.1016/j.idc.2018.02.009

Abstract

The United States has national plans for the elimination of hepatitis C virus but much of US health care is organized on the state level and requires local solutions. This article describes the plans developed by New York, Massachusetts, and the city/county of San Francisco for hepatitis C virus elimination. Coalitions capitalize on existing resources and advocate for new resources to address barriers in hepatitis C virus care. Although each coalition has distinct plans, all share a commitment to groups that are disproportionately affected and are at risk for being excluded from advances in hepatitis C virus treatment and cure.

Keywords: Advocacy; Coalition; Continuum of care; Elimination; Hepatitis C virus; Legal; People who inject drugs.

Publication types

Review

MeSH terms

Adult
Antiviral Agents / administration & dosage
Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use
Continuity of Patient Care / statistics & numerical data
Disease Eradication / economics
Disease Eradication / legislation & jurisprudence*
Disease Eradication / methods
Disease Eradication / statistics & numerical data*
Female
Health Policy
Health Services Accessibility
Hepacivirus / drug effects
Hepacivirus / isolation & purification
Hepatitis C / drug therapy
Hepatitis C / epidemiology*
Hepatitis C / virology
Humans
Male
Middle Aged
Substance Abuse, Intravenous
United States / epidemiology
Young Adult

Substances

Antiviral Agents